| Literature DB >> 30617094 |
Thomas J Dilworth1, Anthony M Casapao2, Omar M Ibrahim3, David M Jacobs4, Dana R Bowers5, Nicholas D Beyda6, Renee-Claude Mercier7.
Abstract
We analyzed the impact of vancomycin (VAN) combined with adjuvant β-lactam therapy (Combo) on persistent (≥5 days) methicillin-resistant Staphylococcus aureus bacteremia versus VAN alone by using pooled data from two previously published observational studies (n = 156). Combo was inversely associated with persistent bacteremia (adjusted odds ratio, 0.460; 95% confidence interval, 0.229 to 0.923). Acute kidney injury was more common with Combo than with VAN (18.9% and 7.6%, respectively; P = 0.062).Entities:
Keywords: bacteremia; combination therapy; methicillin-resistant Staphylococcus aureuszzm321990; vancomycin; β-lactam
Mesh:
Substances:
Year: 2019 PMID: 30617094 PMCID: PMC6395910 DOI: 10.1128/AAC.02211-18
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191